Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Allsop

Showing results (31-40 of 66) with videos related to

Pageof 7
Sort By:
Journal of Neurochemistry|October 11, 2003
Fe(II)-induced DNA damage in alpha-synuclein-transfected human dopaminergic BE(2)-M17 neuroblastoma cells: detection by the Comet assayFrancis L Martin, Sally J M Williamson, Katerina E Paleologou, et al.
Neuroscience Letters|July 2, 2013
Correlation of Aβ oligomer levels in matched cerebrospinal fluid and serum samplesTakashi Kasai, Takahiko Tokuda, Mark Taylor, et al.
Biochemistry|January 15, 2008
Designing peptide inhibitors for oligomerization and toxicity of Alzheimer's beta-amyloid peptideBrian M Austen, Katerina E Paleologou, Sumaya A E Ali, et al.
Biochemistry|March 17, 2010
Development of a proteolytically stable retro-inverso peptide inhibitor of beta-amyloid oligomerization as a potential novel treatment for Alzheimer's diseaseMark Taylor, Susan Moore, Jennifer Mayes, et al.
Scientific Reports|August 30, 2013
A longitudinal study on α-synuclein in blood plasma as a biomarker for Parkinson's diseasePenelope G Foulds, Peter Diggle, J Douglas Mitchell, et al.
Journal of the Neurological Sciences|March 3, 2009
Galantamine inhibits beta-amyloid aggregation and cytotoxicityBalpreet Matharu, Gillian Gibson, Richard Parsons, et al.
Acta Neuropathologica|November 8, 2008
Increased TDP-43 protein in cerebrospinal fluid of patients with amyotrophic lateral sclerosisTakashi Kasai, Takahiko Tokuda, Noriko Ishigami, et al.
ACS Chemical Neuroscience|June 6, 2018
Raman Spectroscopy to Diagnose Alzheimer's Disease and Dementia with Lewy Bodies in BloodMaria Paraskevaidi, Camilo L M Morais, Diane E Halliwell, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|August 26, 2011
Phosphorylated α-synuclein can be detected in blood plasma and is potentially a useful biomarker for Parkinson's diseasePenelope G Foulds, J Douglas Mitchell, Angela Parker, et al.
Acta Neuropathologica|May 29, 2008
TDP-43 protein in plasma may index TDP-43 brain pathology in Alzheimer's disease and frontotemporal lobar degenerationPenelope Foulds, Erica McAuley, Linda Gibbons, et al.
Pageof 7

Showing results (31-40 of 66) with videos related to

Sort By:
Pageof 7
Journal of Neurochemistry|October 11, 2003
Fe(II)-induced DNA damage in alpha-synuclein-transfected human dopaminergic BE(2)-M17 neuroblastoma cells: detection by the Comet assayFrancis L Martin, Sally J M Williamson, Katerina E Paleologou, et al.
Neuroscience Letters|July 2, 2013
Correlation of Aβ oligomer levels in matched cerebrospinal fluid and serum samplesTakashi Kasai, Takahiko Tokuda, Mark Taylor, et al.
Biochemistry|January 15, 2008
Designing peptide inhibitors for oligomerization and toxicity of Alzheimer's beta-amyloid peptideBrian M Austen, Katerina E Paleologou, Sumaya A E Ali, et al.
Biochemistry|March 17, 2010
Development of a proteolytically stable retro-inverso peptide inhibitor of beta-amyloid oligomerization as a potential novel treatment for Alzheimer's diseaseMark Taylor, Susan Moore, Jennifer Mayes, et al.
Scientific Reports|August 30, 2013
A longitudinal study on α-synuclein in blood plasma as a biomarker for Parkinson's diseasePenelope G Foulds, Peter Diggle, J Douglas Mitchell, et al.
Journal of the Neurological Sciences|March 3, 2009
Galantamine inhibits beta-amyloid aggregation and cytotoxicityBalpreet Matharu, Gillian Gibson, Richard Parsons, et al.
Acta Neuropathologica|November 8, 2008
Increased TDP-43 protein in cerebrospinal fluid of patients with amyotrophic lateral sclerosisTakashi Kasai, Takahiko Tokuda, Noriko Ishigami, et al.
ACS Chemical Neuroscience|June 6, 2018
Raman Spectroscopy to Diagnose Alzheimer's Disease and Dementia with Lewy Bodies in BloodMaria Paraskevaidi, Camilo L M Morais, Diane E Halliwell, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|August 26, 2011
Phosphorylated α-synuclein can be detected in blood plasma and is potentially a useful biomarker for Parkinson's diseasePenelope G Foulds, J Douglas Mitchell, Angela Parker, et al.
Acta Neuropathologica|May 29, 2008
TDP-43 protein in plasma may index TDP-43 brain pathology in Alzheimer's disease and frontotemporal lobar degenerationPenelope Foulds, Erica McAuley, Linda Gibbons, et al.
Pageof 7